Development of an Active Site Peptide Analog of α-Fetoprotein That Prevents Breast Cancer

被引：11
|
作者：
Jacobson, Herbert I. [1 ,3 ]
Andersen, Thomas T. [2 ]
Bennett, James A. [3 ]
机构：
[1] Albany Med Coll, Dept Obstet & Gynecol, Albany, NY 12208 USA
[2] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA
[3] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA
来源：
CANCER PREVENTION RESEARCH | 2014年 / 7卷 / 06期
关键词：
ESTROGEN-SENSITIVE CELLS; MAMMARY-TUMOR CELLS; GROWTH-INHIBITION; MATERNAL SERUM; SECRETING HEPATOMA; MULTIPLE BIRTHS; PROBABLE ROLE; TWIN BIRTHS; RISK; RATS;
D O I：
10.1158/1940-6207.CAPR-13-0405
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Epidemiologic studies associate elevated maternal serum levels of alpha-fetoprotein (AFP) with reduced breast cancer risk for parous women. Laboratory studies demonstrate direct anti-breast cancer activity of AFP. Here, we review the development of a small cyclic peptide that is an active site analog of AFP, referred to as AFPep, which is composed exclusively of amino acids, is orally active, has no discernable toxicity, and is effective for the treatment and prevention of breast cancer in animal models. (C)2014 AACR.
引用
收藏
页码：565 / 573
页数：9
相关论文
共 50 条
  • [1] Safe and effective prevention of breast cancer by AFPep, an active site peptide analog of α-fetoprotein
    Andersen, T
    Parikh, RR
    Lemanski, N
    McLeod, D
    Georgekutty, J
    Saadati, H
    Fake, J
    Jacobson, H
    Bennett, JA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1322S - 1322S
  • [2] Prevention of breast cancer by a peptide derived from the active site of alpha-fetoprotein.
    Andersen, TT
    Parikh, R
    McLeod, D
    DeFreest, L
    Jacobson, H
    Bennett, J
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1182S - 1182S
  • [3] Development of a synthetic cyclized peptide derived from α-fetoprotein that prevents the growth of human breast cancer
    Mesfin, FB
    Andersen, TT
    Jacobson, HI
    Zhu, S
    Bennett, JA
    JOURNAL OF PEPTIDE RESEARCH, 2001, 58 (03): : 246 - 256
  • [4] Prevention of N-methyl-N-nitrosourea-induced breast cancer by α-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP
    Parikh, RR
    Gildener-Leapman, N
    Narendran, A
    Lin, HY
    Lemanski, N
    Bennett, JA
    Jacobson, HI
    Andersen, TT
    CLINICAL CANCER RESEARCH, 2005, 11 (23) : 8512 - 8520
  • [5] Dipeptide Analog of Neurotensin Active Site Prevents the Development of Experimental Parkinson's Syndrome in Mice
    V. K. Lutsenko
    M. N. Vukolova
    V. G. Kucheryanu
    T. A. Gudasheva
    Bulletin of Experimental Biology and Medicine, 2003, 136 : 352 - 354
  • [6] Dipeptide analog of neurotensin active site prevents the development of experimental Parkinson's syndrome in mice
    Lutsenko, VK
    Vukolova, MN
    Kucheryanu, VG
    Gudasheva, TA
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 136 (04) : 352 - 354
  • [7] A peptide that prevents breast cancer is fully active after oral administration: AFPep.
    Andersen, TT
    Georgekutty, J
    Anaka, I
    Parikh, R
    Gildener-Leapman, N
    Jacobson, HI
    Bennett, JA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2720S - 2720S
  • [8] Estetrol prevents early breast cancer development
    Itou, Junji
    CANCER SCIENCE, 2025, 116 : 1579 - 1579
  • [9] AN ACTIVE ANALOG OF INACTIVE SLEEP PEPTIDE
    KOVALZON, VM
    KALIKHEVICH, VN
    CHURKINA, SI
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1986, 101 (06) : 789 - 791
  • [10] A peptide derived from α-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen
    Bennett, JA
    Mesfin, FB
    Andersen, TT
    Gierthy, JF
    Jacobson, HI
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) : 2211 - 2215
12345